News | March 07, 2024
Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
Cipla completes transfer of Generics Business Undertaking
Eugia Pharma Specialities restarts production at terminally sterilized product lines
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The observations do not pose any risk to site's compliance standards or its business continuity
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Subscribe To Our Newsletter & Stay Updated
